<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01793272</url>
  </required_header>
  <id_info>
    <org_study_id>11-2-13</org_study_id>
    <nct_id>NCT01793272</nct_id>
  </id_info>
  <brief_title>Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males</brief_title>
  <official_title>Beneficial Effect of Adding Pentoxifylline to Processed Semen Samples on ICSI Outcome in Infertile Males With Mild and Moderate Asthenozoospermia: Randomized Controlled Prospective Crossover Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Adam International Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Adam International Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of pentoxifylline used in preparation of semen samples that will be
      used for ICSI in infertile men complaining of mild and moderate asthenozoospermia (i.e. cases
      which does not need motility enhancement prior to ICSI) in comparison to semen samples
      without pentoxifylline preparation on the outcome of ICSI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary outcome measures were the number of oocytes retrieved, the number of oocytes
      injected, number of oocytes fertilized, fertilization rate, number of embryos and their
      quality (G1: good embryos, G2: fair embryos and G3: bad embryos), number of embryos
      transferred (ET), number of embryo sacs, embryo implantation rate, pregnancy rate and
      abortion rate for all 3 groups and pregnancy rate and abortion rate for both group (I) and
      group (II).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ICSI outcome</measure>
    <time_frame>from October 2010 to April 2011.</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Pentoxifylline Allergy</condition>
  <arm_group>
    <arm_group_label>Pentoxifylline</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>effect of pentoxifylline on ICSI outcome</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>effect of pentoxifylline on ICSI outcome</intervention_name>
    <description>semen processing with pentoxifylline prior to ICSI</description>
    <arm_group_label>Pentoxifylline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  seeking ICSI for infertility

        Exclusion Criteria:

          -  Pyospermia, presence of antisperm antibodies. Azoospermia, severe male factor, severe
             asthenozoospermia. Past history of orchitis. Patients who received empirical treatment
             for asthenozoospermia e.g. oral Pentoxifylline, l-carnitine or antioxidants during the
             past 3 to 6 month. Diabetics, hypertensives or patients with any other chronic
             systemic illnesses. Wife's age more than 35 years. Low antral count. Presence of any
             ovarian factor contributing to infertility e.g. polycystic ovaries.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medhat Amer, MD</last_name>
    <role>Study Director</role>
    <affiliation>M.Amer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Adam International Hospital</name>
      <address>
        <city>Giza</city>
        <zip>12411</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2013</study_first_submitted>
  <study_first_submitted_qc>February 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>February 14, 2013</last_update_submitted>
  <last_update_submitted_qc>February 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Adam International Hospital</investigator_affiliation>
    <investigator_full_name>Ahmad Raef Sadek</investigator_full_name>
    <investigator_title>Ahmad Raef</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pentoxifylline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

